Skip to main content
Market Entry Sprint — reviewed package in 10 business days · from $2,500 · 35+ countries of intelligence.See pricing
GH
For manufacturers

Organize country-entry and launch-readiness work before market execution.

Structure target-country, product, distributor, evidence, regulatory, reimbursement, and launch-readiness questions before committing resources.

Workspace access is invite-only. Market-access content requires professional review before business use.

Who this is for

Healthcare manufacturers evaluating where to prioritize market-entry work.

Commercial, regulatory, reimbursement, and launch teams preparing country questions for review.

Teams organizing product context before distributor search, evidence planning, or launch-readiness work.

Problems GHMAP helps with

Choosing target countries for product expansion

Organizing regulatory questions by country and product type

Preparing distributor search and partner-review context

Identifying evidence gaps before reimbursement or payer discussions

Tracking product launch readiness and next actions

What GHMAP organizes

GHMAP keeps market-access records and open questions structured for review, tracking, and handoff.

Countries

Products

Stakeholders

Regulatory questions

Reimbursement questions

Evidence gaps

Source status

Review status

Next actions

Meeting and request tracking

Example workflow

  1. 1

    Submit company and product context

  2. 2

    Select target countries

  3. 3

    GHMAP structures source gaps and review needs

  4. 4

    Admin or professional review occurs

  5. 5

    A launch-readiness plan can be prepared for business review

What happens after request

The requester receives a reference number.

The requester receives an email when email delivery is configured.

The request can be tracked through Track Request using the reference number and matching email.

GHMAP reviews fit and may request additional information.

Workspace access remains invite-only and reviewed.

Safety boundaries

GHMAP supports market-access intelligence and professional review.

It does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, investment advice, or market-entry guarantees.

For manufacturers

Buy a Market Entry Sprint or strategy session.

Clear packages from $500. Share your product and target country — GHMAP delivers a reviewed outcome with next actions. Professional review required before business use.